Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells

Supportive Care in Cancer

Volumn 22, Issue 6, 2014, Pages 1647-1654

  Fang, Shiuh Bin ^a,b   Shih, Hsin Yu ^c   Huang, Chih Hung ^c   Li, Li Ting ^c   Chen, Chia Chun ^c   Fang, Hsu Wei ^c,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

5 Fluorouracil; Human intestinal epithelium; Interleukin 12; Lactobacillus rhamnosus GG; Monocyte chemotactic protein 1; Tumor necrosis factor

Indexed keywords

CYTOKINE; FLUOROURACIL; INTERLEUKIN 12; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CACO 2 CELL LINE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INTESTINAL MUCOSITIS; INTESTINE EPITHELIUM; LACTOBACILLUS RHAMNOSUS; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SCANNING ELECTRON MICROSCOPY; UPREGULATION;

CACO-2 CELLS; CHEMOKINE CCL2; CYTOKINES; FLUOROURACIL; HUMANS; INTERLEUKIN-12; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84902315852     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2137-z     Document Type: Article

References (42)

1. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98: 1531-1539 (Pubitemid 37151510)
2. Keefe DM (2004) Gastrointestinal mucositis: a new biological model. Support Care Cancer 12:6-9
3. Thorpe DW, Stringer AM, Gibson RJ (2013) Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors. Exp Biol Med (Maywood) 238:1-6
4. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer- Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995-2025 (Pubitemid 38528741)
5. Chang CT, Ho TY, Lin H, Liang JA, Huang HC, Li CC, Lo HY, Wu SL, Huang YF, Hsiang CY (2012) 5-Fluorouracil induced intestinal mucositis via nuclear factor-kappaB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS One 7:e31808
6. Szajewska H, Setty M, Mrukowicz J, Guandalini S (2006) Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr 42:454-475 (Pubitemid 43804722)
7. Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, Joensuu H (2007) Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer 97:1028-1034 (Pubitemid 47587008)
8. Mauger CA, Butler RN, Geier MS, Tooley KL, Howarth GS (2007) Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats. Dig Dis Sci 52:612-619
9. Prisciandaro LD, Geier MS, Chua AE, Butler RN, Cummins AG, Sander GR, Howarth GS (2012) Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage. Support Care Cancer 20:3205-3210
10. Guarner F, Schaafsma GJ (1998) Probiotics. Int J Food Microbiol 39: 237-238 (Pubitemid 28132640)
11. MacGregor G, Smith AJ, Thakker B, Kinsella J (2002) Yoghurt biotherapy: contraindicated in immunosuppressed patients? Postgrad Med J 78:366-367 (Pubitemid 34638894)
12. Li N, Russell WM, Douglas-Escobar M, Hauser N, Lopez M, Neu J (2009) Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res 66:203-207
13. Xiao SD, Zhang DZ, Lu H, Jiang SH, Liu HY, Wang GS, Xu GM, Zhang ZB, Lin GJ, Wang GL (2003) Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther 20:253-260 (Pubitemid 38101668)
14. Sonnier DI, Bailey SR, Schuster RM, Gangidine MM, Lentsch AB, Pritts TA (2012) Proinflammatory chemokines in the intestinal lumen contribute to intestinal dysfunction during endotoxemia. Shock 37:63-69
15. Schauer MC, Holzmann B, Peiper M, Friess H, Knoefel WT, Theisen J (2010) Interleukin-10 and -12 predict chemotherapy-associated toxicity in esophageal adenocarcinoma. J Thorac Oncol 5:1849-1854
16. Schüller S, Lucas M, Kaper JB, Giron JA, Phillips AD (2009) The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection. Cell Microbiol 11:521-530
17. Thirabunyanon M, Boonprasom P, Niamsup P (2009) Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells. Biotechnol Lett 31:571-576
18. Jordan A, Stein J (2003) Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2. Eur J Nutr 42:324-331 (Pubitemid 38055612)
19. Haller D, Blum S, Bode C, Hammes WP, Schiffrin EJ (2000) Activation of human peripheral blood mononuclear cells by non-pathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun 68:752-759 (Pubitemid 30056533)
20. Saegusa S, Totsuka M, Kaminogawa S, Hosoi T (2007) Cytokine responses of intestinal epithelial-like Caco-2 cells to non-pathogenic and opportunistic pathogenic yeasts in the presence of butyric acid. Biosci Biotechnol Biochem 71:2428-2434 (Pubitemid 350106259)
21. Murzyn A, Krasowska A, Augustyniak D, Majkowska-Skrobek G, Lukaszewicz M, Dziadkowiec D (2010) The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407. FEMS Microbiol Lett 310:17-23
22. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25:402-408 (Pubitemid 34164012)
23. Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM (2007) The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33:448-460 (Pubitemid 47324227)
24. Naidu MU, Ramana GV, Rani PU, Mohan IK, Suman A, Roy P (2004) Chemotherapy-induced and/or radiation therapy-induced oral mucositis- complicating the treatment of cancer. Neoplasia 6:423-431 (Pubitemid 39411078)
25. Sakai H, Sagara A,Matsumoto K, Hasegawa S, Sato K, Nishizaki M, Shoji T, Horie S, Nakagawa T, Tokuyama S, Narita M (2013) 5- Fluorouracil induces diarrhea with changes in the expression of inflammatory cytokines and aquaporins in mouse intestines. PLoS One 8:e54788
26. Ferreira TM, Leonel AJ, Melo MA, Santos RR, Cara DC, Cardoso VN, Correia MI, varez-Leite JI (2012) Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration. Lipids 47:669-678
27. Shiota A, Hada T, Baba T, Sato M, Yamanaka-Okumura H, Yamamoto H, Taketani Y, Takeda E (2010) Protective effects of glycoglycerolipids extracted from spinach on 5-fluorouracil induced intestinal mucosal injury. J Med Invest 57:314-320
28. Soares PM, Lima-Junior RC, Mota JM, Justino PF, Brito GA, Ribeiro RA, Cunha FQ, Souza MH (2011) Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemother Pharmacol 68:713-720
29. Reinecker HC, Loh EY, Ringler DJ, Mehta A, Rombeau JL, MacDermott RP (1995) Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 108:40-50
30. Mahoney SE, Davis JM, Murphy EA, McClellan JL, Gordon B, Pena MM(2013) Effects of 5-fluorouracil chemotherapy on fatigue: role of MCP-1. Brain Behav Immun 27:155-161
31. Sergent T, Piront N, Meurice J, Toussaint O, Schneider YJ (2010) Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium. Chem Biol Interact 188:659-667
32. Lan JG, Cruickshank SM, Singh JC, Farrar M, Lodge JP, Felsburg PJ, Carding SR (2005) Different cytokine response of primary colonic epithelial cells to commensal bacteria. World J Gastroenterol 11: 3375-3384 (Pubitemid 40873242)
33. Kaufman HL, Swartout BG, Horig H, Lubensky I (2002) Combination interleukin-2 and interleukin-12 induces severe gastrointestinal toxicity and epithelial cell apoptosis in mice. Cytokine 17: 43-52
34. Jun CD, Kim Y, Choi EY, Kim M, Park B, Youn B, Yu K, Choi KS, Yoon KH, Choi SC, Lee MS, Park KI, Choi M, Chung Y, Oh J (2006) Gliotoxin reduces the severity of trinitrobenzene sulfonic acidinduced colitis in mice: evidence of the connection between heme oxygenase-1 and the nuclear factor-κB pathway in vitro and in vivo. Inflamm Bowel Dis 12:619-629 (Pubitemid 43977744)
35. Zhao J, Huang L, Belmar N, Buelow R, Fong T (2004) Oral RDP58 allows CPT-11 dose intensification for enhanced tumor response by decreasing gastrointestinal toxicity. Clin Cancer Res 10:2851-2859 (Pubitemid 38509165)
36. Mattick KL, Rowbury RJ, Humphrey TJ (2003) Morphological changes to Escherichia coli O157:H7, commensal E. coli and Salmonellaspp in response to marginal growth conditions, with special reference to mildly stressing temperatures. Sci Prog 86:103-113
37. Donato KA, Gareau MG, Wang YJ, Sherman PM (2010) Lactobacillus rhamnosus GG attenuates interferon-γ and tumour necrosis factor-α-induced barrier dysfunction and pro-inflammatory signalling. Microbiology 156:3288-3297
38. Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Bialek D (2007) Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther 25:871-881 (Pubitemid 46525343)
39. Nomoto K, Yokokura T, Nomoto K (1992) Prevention of 5-fluorouracil- induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation. Can J Microbiol 38:774-778
40. Fang HW, Fang SB, Chiang Chiau JS, Yeung CY, Chan WT, Jiang CB, Cheng ML, Lee HC (2010) Inhibitory effects of Lactobacillus casei subsp. rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells. J Med Microbiol 59:573-579
41. Von BI, Adlerberth I, Wold AE, Dahlen G, Jontell M (2003) Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical andmesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol Immunol 18:278-284 (Pubitemid 37087258)
42. Smith CL, Geier MS, Yazbeck R, Torres DM, Butler RN, Howarth GS (2008) Lactobacillus fermentum BR11 and fructooligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutr Cancer 60:757-767